Biggest News Aggregation in the World
๐Ÿ“ฐ Benjamin Bakall News

Benjamin Bakall News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Benjamin Bakall. Real-time updates on events, politics, business and more.

Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024

MALVERN, Pa., April 29, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that...
United States University Of Arizona Benjamin Bakall Ocugen Inc Exchange Commission Clinical Research At Associated Retina Consultants

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410—Modifier Gene Therapy—for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

MALVERN, Pa., Dec. 13, 2023 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today...
United States University Of Arizona Mark Kwong Tarun Upadhyay Shankar Musunuri Benjamin Bakall

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science